Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice
Published: 12 December 2012
The first aim of this ERBP paper is to review the current literature on renal disease in Fabry patients, in order to provide guidance to the nephrologist on when to screen for this disease and why, and to understand the preferred methods that should be used for screening.
The second aim is to provide guidance on the follow-up, prevention and treatment of renal disease, and its complications (proteinuria, renal failure). The role of ERT, angiotensin-converting enzyme inhibitors (ACEi), angiotensin receptor blockers (ARB) and renal replacement therapy (RRT) is reviewed.
Flowchart for screening for fabry disease in Chronic Kidney Disease patients